About MONARCH MEDICAL TECHNOLOGIES

Monarch Medical Technologies is a company that has historically focused on glycemic management solutions within the healthcare sector. The system aims to help healthcare providers achieve and maintain tight glycemic control in hospitalized patients, which is crucial for reducing complications, shortening hospital stays, and improving patient outcomes across various care settings, including critical care, perioperative, and general medical-surgical units.

While the initial query mentioned ‘healthcare AI company,’ it’s important to note that Monarch’s core technology, EndoTool, leverages sophisticated algorithms and predictive analytics to personalize insulin dosing rather than what is typically understood as generative AI or large language models. The system’s intelligence is derived from its ability to analyze patient-specific data, such as blood glucose levels, insulin sensitivity, and clinical context, to generate precise dosing recommendations. This approach helps to minimize the risks associated with hypoglycemia and hyperglycemia, thereby enhancing patient safety and supporting clinical decision-making for endocrinologists, intensivists, and other healthcare professionals managing diabetes in acute care settings.

Focus Areas

inpatient glycemic management clinical decision support for insulin dosing EMR interoperability and HL7 integration clinical analytics and quality measurement for glycemic outcomes implementation and workflow optimization for hospital systems clinical evidence generation and validation of decision support software continuous glucose monitoring implementation and protocol development regulatory compliance and quality systems (FDA 510(k) ISO 13485) algorithm development for safety-focused dosing (residual insulin estimation model predictive control)

Business Intelligence

Technologypredictive therapeutic control technologies, patient-specific algorithms, cloud-based solutions, AI

What Physicians Need to Know

Inpatient Glucose Management
Monarch Medical Technologies specializes in inpatient glucose management with their FDA-cleared EndoTool Glucose Management System. This system is designed to manage blood glucose levels in hospitalized patients, addressing challenges like fluctuating glucose due to critical illness, infection, renal failure, and steroid use. Their solutions aim to avoid severe hyperglycemia and prevent hypoglycemia, which are critical goals in inpatient glycemic management.
Personalized Insulin Dosing
EndoTool provides patient-specific insulin dosing recommendations for both intravenous (IV) and subcutaneous (SubQ) insulin therapy. Unlike traditional 'personalized' approaches that rely on general parameters, EndoTool's algorithm adapts dosing to each patient's unique physiology and real-time condition, considering up to 11 clinical factors such as renal function, steroid use, nutritional intake, and diabetes type. This precision helps reduce the risk of hypoglycemia and ensures safer, more effective treatment.
Clinical Decision Support Software
The EndoTool system functions as a clinical decision support software, guiding clinicians with optimal insulin dosing recommendations. It replaces traditional linear protocols with individualized, predictive computer-based solutions. The software is designed to simplify the complex task of glycemic management, reducing the cognitive burden on healthcare teams and allowing more time for direct patient care.
Predictive Therapeutic Control Technologies & AI/Analytics
Monarch Medical Technologies pioneered the field of predictive therapeutic control technologies. Their EndoTool system utilizes sophisticated and predictive algorithms, including Model Predictive Control and machine-learning adaptive dosing models, to optimize insulin dosing. The system also offers real-time reporting and comprehensive analytics through dynamic dashboards, providing insights into glycemic trends and supporting informed decision-making.
Diabetes Management
Monarch Medical Technologies, now a Glooko Company, is dedicated to advancing glycemic management in hospitals. Their mission is to improve inpatient diabetes care by providing evidence-based, integrated, and innovative insulin dosing solutions. They also aim to bridge the gap between inpatient and outpatient glycemic management through partnerships.
Physician Tip

For physicians, Monarch Medical Technologies' EndoTool system offers a significant advantage by providing patient-specific insulin dosing that adapts to real-time physiological changes, minimizing the risk of hypoglycemia and hyperglycemia. The system's predictive algorithms and clinical decision support reduce the cognitive burden of insulin dosing, allowing for more focus on direct patient care. The comprehensive analytics and reporting features enable quick access to essential data, supporting quality reporting and informed decision-making for improved patient outcomes. Furthermore, the system integrates seamlessly with existing EHRs, streamlining workflows and reducing data entry errors.

Monarch Medical Technologies' EndoTool system is designed for seamless integration with any Electronic Health Record (EHR) system. It utilizes HL7 bi-directional interfacing for exchanging patient, lab, order, and result data, and HTML-based application launches for improved workflow and single sign-on. This allows for automated documentation, reduced data entry, and optimized workflows within existing hospital networks.

Products by MONARCH MEDICAL TECHNOLOGIES

No products listed for this company yet. Know of one? Suggest it →

Videos

News, demos, and interviews about MONARCH MEDICAL TECHNOLOGIES.

Loading videos...

Videos load interactively. If none appear, search YouTube for MONARCH MEDICAL TECHNOLOGIES →

View all on YouTube

No press coverage or publications on file yet. Know of some? Suggest an edit →

Frequently Asked Questions

Monarch Medical Technologies' core product is the EndoTool Glucose Management System, which includes EndoTool IV for intravenous insulin and EndoTool SubQ for subcutaneous insulin. What makes it unique is its patient-specific algorithm that models each patient's clinical characteristics and response to insulin to provide individualized dosing recommendations, aiming to reduce hypoglycemia risk and improve outcomes.
EndoTool utilizes predictive therapeutic control technologies and machine-learning adaptive dosing models. It analyzes patient-specific factors like renal function, steroid use, and nutritional intake to provide real-time, individualized insulin dosing recommendations, which helps prevent excessive insulin administration and reduces the risk of hypoglycemia. The system also offers real-time reporting and dynamic dashboards for insights into glycemic trends and CMS clinical quality measures.
Monarch Medical Technologies' EndoTool is an FDA-cleared Class II medical device. The company ensures compliance with FDA standards (21CFR Part 820.30) and ISO 13485. They actively support and align with the Centers for Medicare and Medicaid Services' (CMS) new electronic clinical quality measures (eCQMs) for severe hypoglycemia and hyperglycemia, which will require mandatory reporting in 2026.
EndoTool is designed for seamless integration with any EHR system using HL7 protocols for bidirectional data exchange, optimizing workflows and minimizing errors. Monarch Medical Technologies provides 24/7/365 technical and clinical support, dedicated customer success managers, and ongoing education through onsite, remote, and eLearning modules.
Monarch Medical Technologies was acquired by Glooko, a global leader in diabetes management solutions, in September 2025. This acquisition aims to create a comprehensive inpatient-to-outpatient diabetes management solution. Monarch also previously partnered with Voluntis to provide a seamless solution for insulin dosing across the continuum of care, bridging inpatient and outpatient glycemic management.
While specific pricing details are not publicly available, studies have shown that implementing EndoTool can lead to significant cost savings for hospitals. For example, one hospital reported a potential annual saving of $75,000 just for treating DKA patients due to reduced length of stay and costs. The system aims to improve patient outcomes, which can indirectly reduce overall healthcare costs.

Related Companies

TaxMCP is an AI tool designed for tax professionals, including CPAs, enrolled agents, and tax attorneys, to conduct U.S. federal and state tax research. It functions as a research connector that integrates with AI assistants like Claude and ChatGPT, allowing users to access source-linked tax authority directly within their conversational AI environment. Instead of operating […]

Stanford University, through its online learning platform Stanford Online (online.stanford.edu), provides a wide array of educational opportunities, including those focused on Artificial Intelligence (AI) in healthcare. Stanford Online aims to extend the university’s academic excellence and breakthrough research to a global audience, offering programs taught by Stanford faculty and industry experts. These offerings range from […]

RTW.ai provides scaled CPA services, offering productized accounting, tax preparation, and quarterly insights specifically for owner-led businesses in healthcare, professional services, and the trades. The company aims to eliminate the common frustrations associated with traditional accounting services, such as slow response times and lack of proactive tax planning. They commit to closing books by the […]

Infinitus is a healthcare AI company that develops voice AI agents and copilots to automate administrative workflows for physicians and healthcare providers. The company aims to reduce the complexity and cost of healthcare by handling time-consuming and repetitive phone-based tasks, such as benefit verifications, prior authorizations, patient outreach, and member engagement. By automating these processes, […]

Trainio is an AI roleplay training platform specifically designed for healthcare teams. It allows medical staff, including front desk personnel, call center agents, caregivers, nurses, and pharmacists, to practice challenging patient and family conversations with realistic AI avatars. These scenarios cover a wide range of situations, such as de-escalation of angry patients, communication with individuals […]

Confido Health is an AI-powered healthcare operations platform designed to alleviate administrative burdens for physicians and healthcare providers. The company develops AI agents that automate routine tasks and workflows across various aspects of healthcare operations, including front, mid, and back office functions. This allows medical staff to dedicate more time to direct patient care, improving […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.